INVESTIGATING THE CANONICAL POLYCOMB REPRESSIVE COMPLEX 1 (CPRC1) AS AN INTRINSIC MECHANISM OF RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER
$1,226,730FY2025Defense Health AgencyDOD
Regents Of The University Of California, San Francisco, The